Centessa Pharmaceuticals (CNTA) Interest & Investment Income (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Interest & Investment Income of $5.1 million for Q1 2026, down 34.88% year-over-year from $7.9 million in Q1 2025, and up 14.38% on a QoQ basis from $4.5 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 7 years of Interest & Investment Income data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Interest & Investment Income fell 34.88% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (down 7.97% YoY) and the FY2025 annual result came in at $20.5 million, up 46.45% from the prior year.
- Interest & Investment Income climbed to $5.1 million in Q1 2026 per CNTA's latest filing, from $4.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.9 million in Q1 2025 and bottomed at $25000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $3.0 million (2023), against an average of $3.0 million.
- The widest annual swing landed in 2023, when Interest & Investment Income soared 8136.0%; it then slumped 34.88% in 2026.
- Tracing CNTA's Interest & Investment Income over 5 years: stood at $39000.0 in 2022, then soared by 7420.51% to $2.9 million in 2023, then surged by 65.19% to $4.8 million in 2024, then declined by 7.29% to $4.5 million in 2025, then advanced by 14.38% to $5.1 million in 2026.
- Per Business Quant, the three latest CNTA Interest & Investment Income figures stand at $5.1 million (Q1 2026), $4.5 million (Q4 2025), and $3.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 5.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 7.89 Mn |
| Dec 31, 2024 | 4.85 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.53 Mn |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | 65,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 8,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Jun 30, 2020 | -17,000.00 |